Diseases Treated
Stem cell transplants have been used since the 1960’s to treat a variety of diseases. In 1988 cord blood stem cells were used for the first time in hematopoietic (blood) stem cell transplantation. Umbilical cord blood stem cells have now been used in more than 15,000 transplants, through 2009, worldwide as a valuable alternative to traditional sources of hematopoietic stem cells. Utilizing the process of stem cell banking, cord blood stem cells also show great promise for potential future applications including treatment and repair of non-hematopoietic tissues, gene therapies, mini-transplants, among others.
Current Stem Cell Applications
Acute Leukemia’s
Chronic Leukemia’s
Myelodysplastic Syndromes
Stem Cell Disorders
Myeloproliferative Disorders
Lymphoproliferative Disorders
Phagocyte Disorders
Other Inherited Disorders
Inherited Platelet Abnormalities
|
Inherited Metabolic Disorders
Histiocytic Disorders
Inherited Erythrocyte Abnormalities
Inherited Immune System Disorders
Plasma Cell Disorders
Other Malignancies
|
Potential Future Applications
|
Alzheimer’s Disease |
Multiple Sclerosis |
This list represents major categories of diseases treated with stem cells and is not exhaustive. For instance, there are more than twenty (20) specific types of Non-Hodgkin’s Lymphoma and numerous types of Chronic Lymphocytic Leukemia, to name just two among many others.
Other cord blood banks include diseases such as breast cancer and testicular cancer. CorCell has chosen not to include these diseases as clinical data has demonstrated that these diseases are not effectively treated with stem cell transplantation.
References include:
- National Marrow Donor Program. www.marrow.org. Accessed 11-18-2003.
- Cord Blood and Our Tomorrow, Larry Lasky, MD. AABB News. March/April 2001. American Association of Blood Banks.
- Tissue Engineering with Bone Marrow and Cord Blood Grows Heart Parts. American Heart Association. Top 10 Research Advances for 2001.
- Impact of Bone Marrow Transplantation on Type 1 diabetes. World Journal of surgery. Vol. 25, No.4. April 2001.
- Dystrophin Expression in the mdx Mouse Restored by Stem Cell Transplantation. Nature. Vol. 401. September 23, 1999.













